Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 3, 2001, Pages 394-396

  Agelink, M W ^a   Andrich, J ^b   Postert, T ^b   Wurzinger U ^b   Zeit, T ^a   Klotz, P ^b   Przuntek, H ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

Electroconvulsive therapy; Epilepsy; Neuron specific enolase; Protein S 100

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S 100;

ADULT; AGED; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CONVULSION; DISEASE ASSOCIATION; DISEASE DURATION; ELECTROCONVULSIVE THERAPY; ENERGY; FEMALE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOMETRY;

EID: 0034885728     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.3.394     Document Type: Article

References (17)

1. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomised, double-blind comparison of bilateral and right lateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-34.
2. Coffey CE, Weiner RD, Djang WT, et al. Brain anatomic effects of electroconvulsive therapy: a prospective magnetic resonance imaging study. Arch Gen Psychiatry 1991;48: 1013-21.
3. Devanand DP, Dwork AJ, Hutchinson ER, et al. Does ECT alter brain structure. Am J Psychiatry 1994;151:957-70.
4. Büttner T, Lack B, Jäger M, et al. Serum levels of neuron-specific enolase and S-100 protein after single tonic-clonic seizures. J Neurology 1999;246:459-61.
5. Ingebrigtsen T, Romner B, Kongstad P, et al. Increased serum concentration of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 1995;59:103-4.
6. Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human nervous system. Stroke 1987;18:911-18.
7. Rasmussen LS, Christiansen M, Hansen PB, et al. Do blood levels of neuron specific enolase and S100 protein reflect cognitive dysfunction after coronary artery bypass? Acta Anaesthesiol Scand 1999;43:495-500.
8. Weiner RD. Electroconvulsive therapy. In: Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry. Baltimore, Williams and Wilkins, 1989:1670-8.
9. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
10. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
11. Kim YS, Overall JE. Factor structure and scoring of the SKT test battery. J Clin Psychology 1991;49:61-71.
12. Büttner T, Weyers S, Postert T, et al. S-100 protein: serum marker of focal brain damage after ischaemic territorial MCA infarction. Stroke 1997;28:1961-5.
13. Rabinowicz AL, Correale JD, Boutros RB, et al. Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring. Epilepsia 1996;37:122-5.
14. Prange HW. Pathophysiologie, Therapie und Prognose des hypoxisch-ischämischen Hirnschadens. Z Kardiol 1994;83: 127-34.
15. Zachrisson OC, Balldin J, Ekman R, et al. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res 2000;96:157-65.
16. Berrouschot J, Rolle K, Kühn HJ, et al. Serum neuron-specific enolase levels do not increase after electroconvulsive therapy. J Neurol Sci 1997;150:173-6.
17. Kragh J, Bolwig TG, Woldby DPD, et al. Electroconvulsive shock and lidocaine-induced seizures in the rat activate astrocytes as measured by glial fibrillary acidic protein. Biol Psychiatry 1993;33:794-800.